| Date Initiated by Firm | September 19, 2022 |
| Date Posted | October 20, 2022 |
| Recall Status1 |
Open3, Classified |
| Recall Number | Z-0104-2023 |
| Recall Event ID |
90900 |
| 510(K)Number | K050374 |
| Product Classification |
Assay, porphyrin, spectrophotometry, lithium - Product Code NDW
|
| Product | Atellica CH Lithium_2 (LITH_2), Siemens Material Number 11532401. in vitro diagnostic assay |
| Code Information |
UDI-DI: 00630414287935
All lots impacted:
Lots
110238 exp 10/18/22
110302 exp 12/13/22
120017 exp 4/18/23 |
| FEI Number |
2432235
|
Recalling Firm/ Manufacturer |
Siemens Healthcare Diagnostics, Inc. 511 Benedict Ave Tarrytown NY 10591-5005
|
| For Additional Information Contact | Jennifer Beecher 914-631-8000 |
Manufacturer Reason for Recall | Potential for falsely elevated LITH_2 and Li results on the Atellica CH 930 Analyzer. In the worst case, there is a potential for erroneously elevated lithium patient results, which may lead to inappropriate dosage adjustment, potentially affecting treatment efficacy. |
FDA Determined Cause 2 | Under Investigation by firm |
| Action | On September 19, 2022, the firm issued an Urgent Medical Device Correction letter to affected customers. Customers should take the following actions:
-Please review this letter with your Medical Director.
-Discontinue use of and discard the affected product.
Siemens is temporarily discontinuing production and distribution of the Atellica CH lithium reagents
until the issue is resolved. In the interim, Siemens is recommending that customers transition to an
alternate lithium assay. |
| Quantity in Commerce | 1342 US; 2266 OUS |
| Distribution | Worldwide distribution - US Nationwide. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|
| 510(K) Database | 510(K)s with Product Code = NDW
|